Načítá se...
Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults
OBJECTIVES: Enhanced inactivated influenza vaccines (eIIV) aim to increase immunogenicity and protection compared with the widely used standard IIV (S‐IIV). METHODS: We tested four vaccines in parallel, FluZone high dose, FluBlok and FluAd versus S‐IIV in a randomised controlled trial of older adult...
Uloženo v:
| Vydáno v: | Clin Transl Immunology |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6997034/ https://ncbi.nlm.nih.gov/pubmed/32025302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1107 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|